No respite in sight as not many big deals, initial public offerings in pipeline.
Property markets in Uttarakhand and Himachal Pradesh, which have had a dream run in recent years, are set to face a downturn.
The FY13 fourth quarter (Q4) earnings, however, fell short of analysts' expectation, as debt was still high at Rs 21,730 crore (Rs 217.3 billion), with much of the targeted non-core sales done.
Despite slowdown, smaller firms attract growth capital.
Experts believe MNCs, which look for a strong foothold in the Indian kitchen appliances space, target the leading organised players in the industry.
With projects ranging from affordable to premium, Tata Housing Development Co Ltd says it expects to be among the top three real estate entities in the next five years.
Experts attribute this to economy slowdown and political uncertainty with the general elections round the corner.
A farmhouse colony would be a cluster of 20-30 farmhouses, each with an area of 1-2.5 acres, spread over at least 100 acres.
In the latest initiative, the US food giant has roped in popular Indian cartoon character Chhota Bheem to sell various items through its retail outlets in India.
However, foreign investors have completely shunned the infrastructure sector.
PE firms are looking at various ways to protect their nominee directors.
The project will have 28 floors, with 324 apartments spread over 16 acres, and is likely to be announced in the next one or two months
Costs on the outskirts soar 50-100% through past year
Last week, Sun's Israeli subsidiary, Taro Pharma, received the US Food and Drug Administration's approval for its New Drug Application to launch Topicort Topical Spray for the treatment of psoriasis.
At Rs 10-25 crore each, with star design and promotion, the segment is supposed to be recession-proof.
According to experts tracking the realty sector, sites such as Magicbricks.com, 99acres.com and makaan.com are fast-becoming the choice of consumers looking for renting a property, as such sites let them directly connect with the owner and save time and money.
Compulsory licence application filed for anti-cancer drug of Bristol Myers Squibb; more to come for four drugs.
Brian Druker, who invented the drug's molecule, says it would benefit patients in the short term.
Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up.
The tie-up with IBM for Wave City, to be spread over 4,500 acres, is meant to provide information on traffic management through SMS alerts and billing usage.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances